Polysaccharides of shoots Solanum tuberosum (Polysaccharides of shoots Solanum tuberosum)

Pharmacodynamics Pharmacokinetics Indications Carefully Contraindications Dosing and Administration Side effects
Read on
Clinical and pharmacological group: & nbsp

Antiviral drugs (excluding HIV)

Included in the formulation
  • Panavir®
    suppositories rect. 
    NATIONAL RESEARCH COMPANY, LTD.     Russia
  • Panavir®
    gel locally externally 
    NATIONAL RESEARCH COMPANY, LTD.     Russia
  • Panavir®
    suppositories the vagina. 
    NATIONAL RESEARCH COMPANY, LTD.     Russia
  • Panavir®
    solution in / in 
    NATIONAL RESEARCH COMPANY, LTD.     Russia
    • АТХ:

    J.05.A.X   Other antiviral drugs

    Pharmacodynamics:

    High-molecular polysaccharide from the class of hexose glycosides increases non-specific resistance to various infections, induces production of interferon.

    Pharmacokinetics:

    With intravenous administration, after 5 minutes, it is found in the spleen and liver, after 20-30 minutes the drug is found in the exhaled air and urine.

    Indications:
    • Complex therapy of tick-borne encephalitis
    • Complex therapy of herpesviral infections of various localizations
    • Reduced immunity against viral diseases
    • Complex therapy of papillomavirus infection
    • Cytomegalovirus infection
    ICD-10

    I.A50-A64.A60   Anogenital herpetic viral infection [herpes simplex]

    I.A50-A64.A63.0   Anogenital (venereal) warts

    I.A80-A89.A84   Tick-borne viral encephalitis

    I.B00-B09.B00   Infections caused by the herpes simplex virus [herpes simplex]

    I.B00-B09.B00.5   Herpetic eye disease

    I.B00-B09.B00.9   Herpetic infection, unspecified

    I.B00-B09.B02.3   Shingles with eye complications

    I.B25-B34.B25   Cytomegalovirus

    I.B95-B97.B97.7   Papillomaviruses as a cause of diseases classified elsewhere

    I.B99   Other infectious diseases

    III.D80-D89.D84.9   Immunodeficiency, unspecified

    VI.G60-G64.G63.0 *   Polyneuropathy in infectious and parasitic diseases classified elsewhere

    X.J00-J06.J06   Acute upper respiratory tract infections of multiple and unspecified sites

    X.J10-J18.J11   Influenza, virus not identified

    XI.K20-K31.K25   Stomach ulcer

    XI.K20-K31.K26   Duodenal ulcer

    XIII.M05-M14.M06.9   Rheumatoid arthritis, unspecified

    XIV.N40-N51.N41.1   Chronic prostatitis

    XV.O20-O29.O26.2   Medical care for a woman with a habitual miscarriage of pregnancy

    Contraindications:
    • Diseases of the liver
    • Lactation
    • Childhood
    • Kidney Diseases
    Carefully:

    Pregnancy.

    Pregnancy and lactation:

    Category by FDA not determined. Do not use when breastfeeding, use during pregnancy is only possible if the potential benefit to the mother exceeds the potential harm to the child.

    Dosing and Administration:

    Intravenously struino slowly 200 mcg, with tick-borne encephalitis, the administration is carried out twice with an interval of 24-48 hours. The course of treatment can be repeated in a month.

    With cytomegalovirus infection, papillomovirus infection is administered 3 times at intervals of 2 days 1 week, then 2 weeks 2 times at intervals of 3 days.

    Side effects:

    Allergic reactions.

    Overdose:

    Not described.

    Interaction:

    Not described.

    Special instructions:

    Impact on the ability to drive vehicles and manage mechanisms not found.

    Instructions
    Up